Details
| Translated title of the contribution | Economic evaluation of physiological electrolyte therapy in cardiac rhythm problems |
|---|---|
| Original language | Multiple languages |
| Pages (from-to) | 153-160 |
| Number of pages | 8 |
| Journal | Gesundheitsokonomie und Qualitatsmanagement |
| Volume | 6 |
| Issue number | 6 |
| Early online date | 19 Dec 2001 |
| Publication status | Published - Dec 2001 |
Abstract
Aim: The costs of physiological electrolyte therapy in cardiac rhythm problems and its benefit will be evaluated. Method: In accordance with the German recommendations/guidelines on health economic evaluations, a record of costs will be carried out for the treatment of cardiac rhythm problems with potassium and magnesium, a synthetic antiarrhythmic drug, synthetic antiarrhythmic drug and potassium/magnesium. A decision tree will be developed from the data in order to estimate the resulting costs of cardiac rhythm problems. As a further ground for discussion, the quality of life will be measured using the SF-36 and EQ-5D. Results: The treatment costs of 172 study participants totalled 621,175 DM per year, equal to approximately 3,610 DM per patient. Patients who take the electrolyte preparation generate considerably more costs (up to 3,980 DM) than those patients who do not (795 DM), as the dose resulted additionally in the classical antiarrhythmica. The decision tree analysis shows, however, that the intake of the potassium-magnesium preparation leads to a less frequent claim for cost-inducing care programmes, to the extent that after three years of treatment up to 550 DM can be saved. Conclusion: The decision tree analysis shows that a long term administration of a medicine with a potassium/magnesium preparation can reduce costs, despite the electrolyte therapy being on average 515 DM more expensive.
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
In: Gesundheitsokonomie und Qualitatsmanagement, Vol. 6, No. 6, 12.2001, p. 153-160.
Research output: Contribution to journal › Article › Research › peer review
}
TY - JOUR
T1 - Ökonomische Evaluation der Physiologischen Elektrolyttherapie bei Herzrhythmusstörungen
AU - Graf, J. M.
AU - Uber, A.
PY - 2001/12
Y1 - 2001/12
N2 - Aim: The costs of physiological electrolyte therapy in cardiac rhythm problems and its benefit will be evaluated. Method: In accordance with the German recommendations/guidelines on health economic evaluations, a record of costs will be carried out for the treatment of cardiac rhythm problems with potassium and magnesium, a synthetic antiarrhythmic drug, synthetic antiarrhythmic drug and potassium/magnesium. A decision tree will be developed from the data in order to estimate the resulting costs of cardiac rhythm problems. As a further ground for discussion, the quality of life will be measured using the SF-36 and EQ-5D. Results: The treatment costs of 172 study participants totalled 621,175 DM per year, equal to approximately 3,610 DM per patient. Patients who take the electrolyte preparation generate considerably more costs (up to 3,980 DM) than those patients who do not (795 DM), as the dose resulted additionally in the classical antiarrhythmica. The decision tree analysis shows, however, that the intake of the potassium-magnesium preparation leads to a less frequent claim for cost-inducing care programmes, to the extent that after three years of treatment up to 550 DM can be saved. Conclusion: The decision tree analysis shows that a long term administration of a medicine with a potassium/magnesium preparation can reduce costs, despite the electrolyte therapy being on average 515 DM more expensive.
AB - Aim: The costs of physiological electrolyte therapy in cardiac rhythm problems and its benefit will be evaluated. Method: In accordance with the German recommendations/guidelines on health economic evaluations, a record of costs will be carried out for the treatment of cardiac rhythm problems with potassium and magnesium, a synthetic antiarrhythmic drug, synthetic antiarrhythmic drug and potassium/magnesium. A decision tree will be developed from the data in order to estimate the resulting costs of cardiac rhythm problems. As a further ground for discussion, the quality of life will be measured using the SF-36 and EQ-5D. Results: The treatment costs of 172 study participants totalled 621,175 DM per year, equal to approximately 3,610 DM per patient. Patients who take the electrolyte preparation generate considerably more costs (up to 3,980 DM) than those patients who do not (795 DM), as the dose resulted additionally in the classical antiarrhythmica. The decision tree analysis shows, however, that the intake of the potassium-magnesium preparation leads to a less frequent claim for cost-inducing care programmes, to the extent that after three years of treatment up to 550 DM can be saved. Conclusion: The decision tree analysis shows that a long term administration of a medicine with a potassium/magnesium preparation can reduce costs, despite the electrolyte therapy being on average 515 DM more expensive.
KW - Cardiac rhythm problems
KW - Costs
KW - Electrolyte therapy
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=0035670814&partnerID=8YFLogxK
U2 - 10.1055/s-2001-19186
DO - 10.1055/s-2001-19186
M3 - Article
AN - SCOPUS:0035670814
VL - 6
SP - 153
EP - 160
JO - Gesundheitsokonomie und Qualitatsmanagement
JF - Gesundheitsokonomie und Qualitatsmanagement
SN - 1432-2625
IS - 6
ER -